These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1594638

  • 1. Minaprine cancels scopolamine effects on the rat's acquisition of passive avoidance responses in two multitrial paradigms.
    Ambrogi Lorenzini C, Baldi E, Bucherelli C, Tassoni G.
    Pharmacol Biochem Behav; 1992 Apr; 41(4):715-8. PubMed ID: 1594638
    [Abstract] [Full Text] [Related]

  • 2. Minaprine facilitates acquisition and retrieval of an active avoidance response in the rat.
    Lorenzini CA, Baldi E, Bucherelli C, Tassoni G.
    Pharmacol Biochem Behav; 1993 Jun; 45(2):481-5. PubMed ID: 8327555
    [Abstract] [Full Text] [Related]

  • 3. Effect of minaprine on cycloheximide-induced amnesia in mice.
    Nabeshima T, Kawashima K, Kameyama T.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):249-57. PubMed ID: 2530096
    [Abstract] [Full Text] [Related]

  • 4. Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
    Yamamoto T, Yatsugi S, Ohno M, Furuya Y, Kitajima I, Ueki S.
    Psychopharmacology (Berl); 1990 Oct 10; 100(3):316-22. PubMed ID: 2315427
    [Abstract] [Full Text] [Related]

  • 5. Cholinomimetic activities of minaprine.
    Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct 10; 340(4):411-8. PubMed ID: 2586634
    [Abstract] [Full Text] [Related]

  • 6. Cholinomimetic activity of minaprine is related to the amelioration of delayed neuronal death in gerbils.
    Karasawa Y, Araki H, Otomo S.
    Physiol Behav; 1992 Jul 10; 52(1):141-7. PubMed ID: 1528997
    [Abstract] [Full Text] [Related]

  • 7. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.
    Pitsikas N, Rigamonti AE, Cella SG, Locatelli V, Sala M, Muller EE.
    Eur J Pharmacol; 2001 Aug 31; 426(3):193-200. PubMed ID: 11527544
    [Abstract] [Full Text] [Related]

  • 8. Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice.
    Nomura Y, Nishiyama N, Saito H, Matsuki N.
    Biol Pharm Bull; 1994 Apr 31; 17(4):490-4. PubMed ID: 8069254
    [Abstract] [Full Text] [Related]

  • 9. Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice.
    Silva RH, Felicio LF, Frussa-Filho R.
    Psychopharmacology (Berl); 1999 Jan 31; 141(2):111-7. PubMed ID: 9952034
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols.
    Elrod K, Buccafusco JJ.
    Pharmacol Biochem Behav; 1988 Jan 31; 29(1):15-21. PubMed ID: 3353420
    [Abstract] [Full Text] [Related]

  • 11. Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both?
    Quirarte GL, Cruz-Morales SE, Cepeda A, García-Montañez M, Roldán-Roldán G, Prado-Alcalá RA.
    Behav Neural Biol; 1994 Jul 31; 62(1):15-20. PubMed ID: 7945140
    [Abstract] [Full Text] [Related]

  • 12. Shuttle-box avoidance facilitation by minaprine in mice.
    Sansone M, Battaglia M, Vetulani J.
    Pol J Pharmacol Pharm; 1990 Jul 31; 42(4):321-6. PubMed ID: 2097593
    [Abstract] [Full Text] [Related]

  • 13. Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.
    Sałat K, Podkowa A, Malikowska N, Trajer J.
    Toxicol Mech Methods; 2017 Mar 31; 27(3):181-190. PubMed ID: 27996351
    [Abstract] [Full Text] [Related]

  • 14. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.
    Sansone M, Battaglia M, Vetulani J.
    Pol J Pharmacol; 1995 Mar 31; 47(1):69-73. PubMed ID: 7550552
    [Abstract] [Full Text] [Related]

  • 15. Negative and positive effects of intracerebroventricular scopolamine on memory in mice undergoing passive avoidance and escape tests.
    Nakajima M, Inui A, Miura M, Hirosue Y, Okita M, Himori N, Baba S, Kasuga M.
    Brain Res Bull; 1994 Mar 31; 34(4):375-80. PubMed ID: 8082028
    [Abstract] [Full Text] [Related]

  • 16. A threshold for the protective effect of over-reinforced passive avoidance against scopolamine-induced amnesia.
    Cruz-Morales SE, Duran-Arevalo M, Diaz Del Guante MA, Quirarte G, Prado-Alcala RA.
    Behav Neural Biol; 1992 May 31; 57(3):256-9. PubMed ID: 1616458
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
    Mansouri MT, Farbood Y, Naghizadeh B, Shabani S, Mirshekar MA, Sarkaki A.
    Pharm Biol; 2016 Oct 31; 54(10):1947-53. PubMed ID: 26828763
    [Abstract] [Full Text] [Related]

  • 18. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM.
    Neuropsychopharmacology; 2004 Jan 31; 29(1):93-100. PubMed ID: 14571256
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of memory disturbance during stages of memory acquisition and fixation.
    Sprints AM.
    Neurosci Behav Physiol; 1989 Jan 31; 19(5):387-92. PubMed ID: 2615946
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
    Yamamura M, Kinoshita K, Nakagawa H, Ishida R.
    Jpn J Pharmacol; 1991 Feb 31; 55(2):241-53. PubMed ID: 1906119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.